Literature DB >> 6267131

Regulation by PGE2 of the production of oxygen intermediates by LPS-activated macrophages.

Z Metzger, J T Hoffeld, J J Oppenheim.   

Abstract

The regulation by prostaglandin E2 (PGE2) of production of oxygen radicals by bacterial lipopolysaccharide-(LPS) activated macrophages was studied in vitro. A 48-hr incubation of murine thioglycollate-elicited macrophages with LPS (0.1 micrograms/ml) resulted in an enhanced ability of these cells to produce oxygen radicals when challenged with phorbol myristate acetate (PMA). Macrophages incubated for 48 hr without LPS did not produce measurable amounts of oxygen radicals when exposed to this triggering stimulus. Thus, PMA-triggered production of oxygen radicals was the result of macrophage activation by LPS. The PMA-triggered production of oxygen radicals by the LPS-activated macrophages was inhibited when PGE2 (10(-5) to 10(-9) M) was present during the incubation with LPS. Inhibition by PGE2 occurred during the early stages of macrophage activation, since the addition of PGE2 24 hr after LPS no longer inhibited the production of oxygen radicals by the macrophages. This inhibitory effect of PGE2 on the LPS-induced activation of macrophages could be reproduced by cyclic-adenosine-monophosphate (cAMP) agonists, such as isoproterenol and cholera toxin as well as by the cAMP analog dibutyryl-cAMP, suggesting a cAMP-mediated mechanism for the inhibitory effect of PGE2 on macrophage activation by LPS. Previous reports have implicated prostaglandins as mediators of destructive processes associated with chronic inflammation. Our findings suggest that PGE2 may, on the other hand, reduce tissue damage in a chronic inflammatory site by inhibiting the production of oxygen radicals by macrophages activated in the sera.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6267131

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

1.  Immunosuppressive properties of Actinobacillus actinomycetemcomitans leukotoxin.

Authors:  G Rabie; E T Lally; B J Shenker
Journal:  Infect Immun       Date:  1988-01       Impact factor: 3.441

2.  Development of antitumor activity in LPS-stimulated mouse granuloma macrophages. Regulation by eicosanoids.

Authors:  J C Drapier; J F Petit
Journal:  Inflammation       Date:  1986-06       Impact factor: 4.092

3.  Peripheral blood and intrarenal phagocytic chemiluminescence during acute kidney graft rejection.

Authors:  F Schödel; F Krombach; C Hammer; W Brendel
Journal:  Inflammation       Date:  1986-09       Impact factor: 4.092

4.  Aging results in accumulation of M1 and M2 hepatic macrophages and a differential response to gadolinium chloride.

Authors:  Steven A Bloomer; Eric D Moyer; Kyle E Brown; Kevin C Kregel
Journal:  Histochem Cell Biol       Date:  2019-11-06       Impact factor: 4.304

Review 5.  The role of lymphokines in delayed-type hypersensitivity reactions.

Authors:  C L Geczy
Journal:  Springer Semin Immunopathol       Date:  1984

6.  In vivo indomethacin treatment causes microglial activation in adult mice.

Authors:  M M Prechel; C Ding; R L Washington; M S Kolodziej; M R Young
Journal:  Neurochem Res       Date:  2000-03       Impact factor: 3.996

7.  Oxygen radical production by peritoneal macrophages and Kupffer cells elicited with Lactobacillus casei.

Authors:  S Hashimoto; K Nomoto; T Matsuzaki; T Yokokura; M Mutai
Journal:  Infect Immun       Date:  1984-04       Impact factor: 3.441

8.  Modulation of metastatic ability by inhibition of cholesterol synthesis.

Authors:  W J Kort; W C Hülsmann; T E Stehman
Journal:  Clin Exp Metastasis       Date:  1989 Sep-Oct       Impact factor: 5.150

9.  Production of superoxide anion, prostaglandins, and hydroxyeicosatetraenoic acids by macrophages from hypersensitivity-type (Schistosoma mansoni egg) and foreign body-type granulomas.

Authors:  S W Chensue; S L Kunkel; G I Higashi; P A Ward; D L Boros
Journal:  Infect Immun       Date:  1983-12       Impact factor: 3.441

10.  Cyclic AMP inhibition of lipopolysaccharide-induced restriction of Legionella pneumophila growth in macrophage cultures.

Authors:  K Egawa; T W Klein; Y Yamamoto; C A Newton; H Friedman
Journal:  Infect Immun       Date:  1992-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.